Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Incyte Corp, Regeneron Pharmaceuticals Inc, Biogen Inc, AbbVie Inc, Gilead Sciences Inc, Amgen Inc, Moderna Inc. and Vertex Pharmaceuticals Inc.
3/27/2023 Health Care Sector Biotechnology Industry
$280,444
Change: -0.56%
Open: $282,995
High: $284,223
Low: $279,341
| Incyte Corp (INCY) |
+0.83%
|
| Regeneron Pharmaceuticals Inc (REGN) |
+0.05%
|
| Biogen Inc (BIIB) |
-0.02%
|
| AbbVie Inc (ABBV) |
-0.30%
|
| Gilead Sciences Inc (GILD) |
-0.52%
|
| Amgen Inc (AMGN) |
-0.53%
|
| Biotechnology Industry |
-0.56%
|
| Moderna Inc. (MRNA) |
-1.68%
|
| Vertex Pharmaceuticals Inc (VRTX) |
-1.88%
|
Index Value: $280,444 -0.56%
Volume: 4.23B Average Volume (3 month): 8.12B
Market Capitalization: N/A
EBITDA: N/A
PEG Ratio (5 year Expected): N/A
Dividend Yield: N/A
Dividend Rate: N/A
Dividend Yield (Forward): N/A
Dividend Rate (Forward): N/A
Shares Outstanding: N/A
Book Value: N/A
Short Ratio: N/A
Price Target (1 year): N/A
Volume: 4.23B Average Volume (3 month): 8.12B
Market Capitalization: N/A
EBITDA: N/A
PEG Ratio (5 year Expected): N/A
Dividend Yield: N/A
Dividend Rate: N/A
Dividend Yield (Forward): N/A
Dividend Rate (Forward): N/A
Shares Outstanding: N/A
Book Value: N/A
Short Ratio: N/A
Price Target (1 year): N/A
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| INCY | Incyte Corp | 70.81 | +0.83% | 1.35M | 0.80 | 2.02% |
| REGN | Regeneron Pharmaceuticals Inc | 820.41 | +0.05% | 801,821 | 1.25 | 11.26% |
| BIIB | Biogen Inc | 269.98 | -0.02% | 570,182 | 0.57 | 4.98% |
| ABBV | AbbVie Inc | 157.54 | -0.30% | 2.42M | 0.38 | 35.48% |
| GILD | Gilead Sciences Inc | 79.58 | -0.52% | 3.76M | 0.61 | 12.69% |
| AMGN | Amgen Inc | 236.76 | -0.53% | 2.06M | 0.83 | 16.14% |
| Biotechnology Industry | 280,444.49 | -0.56% | 4.23B | 0.52 | 13.02% | |
| MRNA | Moderna Inc. | 148.35 | -1.68% | 2.62M | 0.71 | 7.30% |
| VRTX | Vertex Pharmaceuticals Inc | 308.47 | -1.88% | 1.05M | 0.82 | 10.13% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| INCY | Incyte Corp | 15.659B | 1.12 | |
| REGN | Regeneron Pharmaceuticals Inc | 89.647B | -1.17 | |
| BIIB | Biogen Inc | 39.016B | 11.61 | |
| ABBV | AbbVie Inc | 278.769B | 3.68% | -5.61 |
| GILD | Gilead Sciences Inc | 99.769B | 3.71% | 4.58 |
| AMGN | Amgen Inc | 127.102B | 3.33% | 3.18 |
| Biotechnology Industry | N/A | N/A | N/A | |
| MRNA | Moderna Inc. | 58.191B | 1.34 | |
| VRTX | Vertex Pharmaceuticals Inc | 80.827B | 3.68 | |
Back to Market Summary